Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline
- 94 Downloads
Purpose of Review
To examine the impact of the new 2017 ACC/AHA hypertension guideline on the prevalence of hypertension, its constituent ratio, and their associated factors in southwest China.
A total of 14,220 permanent residents ≥ 18 years were enrolled in this survey. According to the 2017 ACC/AHA hypertension guideline, the hypertension prevalence was substantially increased (46.9% vs. 24.5%); consistent across different age and gender groups, while the hypertension awareness (23.8% vs. 45.6%); treatment (18.6% vs. 35.5%); control (2.3% vs. 11.2%); and control among treatment (9.6% vs. 24.0%) patients were decreased in southwest of China. In our cohort, 31.1% participants were newly diagnosed as hypertension. Young adults accounted considerable proportion in this newly diagnosed hypertension population. The proportion of young hypertensive individuals substantially increased, whereas those of the older hypertensive subjects decreased. Among the hypertensive subjects aged ≥ 65 years undergoing treatment, 90% of the elderly subjects were not eligible for hypertension control and 32.5% have systolic blood pressure control at 130–149 mmHg, and thus need to intensify antihypertensive treatment according to 2017 ACC/AHA hypertension guideline. Smoking, drinking, body fat percentage, and body mass index were considered the factors associated with hypertension according to the Chinese hypertension guideline but not in the 2017 ACC/AHA hypertension guideline.
The adoption of the 2017 ACC/AHA hypertension guideline will substantially increase hypertension prevalence in southwest of China. The new definition of hypertension implies that more young adults will likely suffer from high cardiovascular risks, while additional one third of elder hypertensive subjects will likely need intensified antihypertension treatments.
KeywordsHypertension Prevalence Control rate 2017 ACC/AHA hypertension guideline Chinese hypertension guideline
Compliance with Ethical Standards
Conflict of Interest
This study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University and all subjects signed informed consent for data collection and analyses prior to participation.
Dan Li, Xiaofang Zeng, Yi Huang, Han Lei, Ge Li, Nan Zhang, and Wei Huang declare that they no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Xu X, Byles J, Shi Z, McElduff P, Hall J. Dietary pattern transitions, and the associations with BMI, waist circumference, weight and hypertension in a 7-year follow-up among the older Chinese population: a longitudinal study. BMC Public Health. 2016;16(743):743. https://doi.org/10.1186/s12889-016-3425-y.CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251–72. https://doi.org/10.1016/S0140-6736(15)00551-6.CrossRefPubMedGoogle Scholar
- 5.World Health Organization. A global brief on hypertension : silent killer, global public health crisis: World Health Day 2013. World Health Organization. 2013. http://www.who.int/iris/handle/10665/79059.
- 10.•• Li Y, Yang L, Wang L, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516–23. https://doi.org/10.1016/j.ijcard.2016.10.110 This epidemiological study describes the severe burden of hypertension in China from the aspects of hypertension prevalence, awareness, treatment, and control rates. CrossRefPubMedGoogle Scholar
- 11.•• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2018;71(19):e127–248. https://doi.org/10.1016/j.jacc.2017.11.006 This comprehensive guideline redefines the hypertension criteria which will have a major impact on the assessment and management of hypertension around the world. CrossRefPubMedGoogle Scholar
- 12.•• Muntner P, Carey RM, Gidding S, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018;137(2):109–18. https://doi.org/10.1161/CIRCULATIONAHA.117.032582 This article carefully analyzes the potential impact of new hypertension guidelines on the assessment and management of hypertension in the USA. CrossRefPubMedGoogle Scholar
- 15.• Yang C, Wang J, Gao B, et al. Prevalence and treatment of hypertension in China: impacts of 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Sci Bull. 2018;63(8):488–93. https://doi.org/10.1016/j.scib.2018.03.006 This article analyzes the impact of new guidelines on hypertension prevalence and treatment in China. CrossRefGoogle Scholar
- 16.• Khera R, Lu Y, Lu J, et al. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. Bmj. 2018;362:k2357. https://doi.org/10.1136/bmj.k2357 The study analyzes the effects of the 2017 ACC/AHA guidelines on the prevalence of hypertension and antihypertensive treatment in the USA and China. CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Listed N. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet. 1995; 346(8991-8992):1647–1653. https://doi.org/10.1016/S0140-6736(95)92836-7.
- 24.•• Lacey B, Lewington S, Clarke R, et al. Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0·5 million adults in China: a prospective cohort study. Lancet Global Health. 2018;6(6):e641–9. https://doi.org/10.1016/S2214-109X(18)30217-1 This study analyzes the age-specific association between blood pressure and vascular and nonvascular chronic diseases in China and suggest the highly association of blood pressure with intracerebral haemorrhage and ischaemic stroke in Chinese population. CrossRefPubMedGoogle Scholar
- 25.•• Messerli FH, Bangalore S, Messerli AW. Age, blood pressure targets, and guidelines: rift between those who preach, those who teach, and those who treat? Circulation. 2018;138(2):128–30. https://doi.org/10.1161/CIRCULATIONAHA.118.034390 This very useful review describes the effect of age on blood pressure and the blood presuure for the elder people.. CrossRefPubMedGoogle Scholar
- 28.Peng J, Lu F, Wang Z, Zhong M, Sun L, Hu N, et al. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc. 2014;15(12):904–10. https://doi.org/10.1016/j.jamda.2014.07.005.CrossRefPubMedGoogle Scholar